Immunotherapy in Recurrent Ovarian Cancer
Background/Objectives: It remains challenging to treat recurrent ovarian cancer effectively as traditional interventions like chemotherapy and surgery have limited long-term efficacy, highlighting an urgent need for innovative approaches. Immunotherapy offers potential advantages in modulating the i...
Saved in:
| Main Authors: | Keyao Chen, Jingjing Wang, Meng Yang, Shaoqiong Deng, Li Sun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/1/168 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The emerging role of glycolysis and immune evasion in ovarian cancer
by: Bowen Jin, et al.
Published: (2025-03-01) -
FAM111B Overexpression and Immune Cell Infiltration: Implications for Ovarian Cancer Immunotherapy
by: Wanying Li, et al.
Published: (2025-05-01) -
Construction of mitochondrial signature (MS) for the prognosis of ovarian cancer
by: Miao Ao, et al.
Published: (2025-07-01) -
The role of MUC16 in tumor biology and tumor immunology in ovarian cancer
by: Na Yang, et al.
Published: (2025-02-01) -
Immunotherapy for Platinum-Resistant Ovarian Cancer as a Glimmer of Hope
by: Jan Brancewicz, et al.
Published: (2025-06-01)